Navigation Links
Ajinomoto Althea Inc. Appoints J. David Enloe Jr. as President and Chief Executive Officer
Date:1/6/2014

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Ajinomoto Althea Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today the appointment of J. David Enloe Jr. as President and CEO. Mr. Enloe will be responsible for developing strategies to support the company's continued growth.

(Logo: http://photos.prnewswire.com/prnh/20131104/LA10040LOGO)

"We are delighted to welcome David as the new leader of Ajinomoto Althea's management team," said Dr. Hiroshi Shiragami, Co-Chair of Ajinomoto Althea Inc. "His unique depth of experience in the biotechnology industry, leadership abilities, financial management, manufacturing and contractual negotiation skills will be instrumental in supporting further expansion of our business."  

Mr. Enloe brings over 20 years of executive management experience most of that in biotechnology, drug development, and GMP manufacturing management.  Most recently, he served as the Head of the Viral Therapeutics Business Unit at Lonza AG, which provides process development, scale-up and GMP manufacturing of viral-based biologics for clients in the US, Europe and Asia.  David was the founder and CEO of Vivante GMP Solutions, Inc., which he subsequently sold to Lonza AG in 2010. Prior to this, he was President and CEO of Introgen Therapeutics, Inc., which later became the basis for Vivante.

"I can't think of a better fit for Ajinomoto Althea.  David's leadership and experience combined with the Ajinomoto Althea team will enhance the company's position as the most trusted outsource manufacturer for those developing tomorrow's successful therapeutics," stated Dr. Magda Marquet, Co-Chair of Ajinomoto Althea Inc.

"I am thrilled to be joining Ajinomoto Althea Inc. at this exciting stage in its history.  Althea has been an outstanding organization for many years now, and with the recent acquisition by Ajinomoto, the company is positioned to expand and grow into an even more significant player in the biologics production and fill/finish markets. The timing of this opportunity for me was perfect and I can't wait to get started," said Mr. Enloe.

Mr. Enloe joined the team effective December 16, 2013.  Dr. Hiroshi Shiragami and Dr. Magda Marquet will continue to serve Ajinomoto Althea Inc. as Co-Chairs of the Board of Directors.

About Ajinomoto Althea  Inc.

Ajinomoto Althea, Inc. is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services.  Ajinomoto Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Ajinomoto Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Ajinomoto Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Ajinomoto Althea also has an innovative and proven recombinant protein expression technology called Corynex®. For more information visit us at WWW.ALTHEATECH.COM.


'/>"/>
SOURCE Ajinomoto Althea Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shanghai Ajinomoto Amino Acid Co., Ltd. Expands Amino Acid Production Capacity
2. Ajinomoto Althea, Inc. Selected As A Finalist In 26TH Annual CONNECT Most Innovative New Product Awards
3. Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.
4. Ajinomoto Co., Inc. Agrees To Acquire Althea Technologies, Inc.
5. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
6. Concord Medical Announces Results of 2013 Annual General Meeting; Appoints New Board Members
7. ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
8. BioMed Realty Trust Appoints Dr. William R. Brody, President Of The Salk Institute, To Its Board Of Directors
9. Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer
10. Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
11. Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... YORK , May 25, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... Syringe, Insulin Pump and Others)" published by P&S Market ... at $9,998.3 million in 2015, and it is expected ... Based on type, the insulin pump segment is expected ...
(Date:5/25/2016)... Inivata, a global clinical ... tumour DNA (ctDNA) analysis to improve personalised healthcare ... Clive Morris as Chief Medical Officer. ... development programme, scientific collaborations, and through to commercialisation ... in clinical outcomes for patients. Clive ...
(Date:5/24/2016)...   , Study met ... and superiority in , Excellent plus ... of the ascending colon   , ... B.V. today announced new positive data from the phase III MORA ... standard 2 litre PEG with ascorbate. The study met both primary ...
Breaking Medicine Technology:
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... health care world, this installment is bolstered by inspiring human interest stories, courtesy ... to the developing trends and tech within the industry, from leading advocates and ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... name in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, ... (SIC), providing proof of successfully certified products, services and staff. , Validation Center ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., the maker ... 2016 When Work Works Award for its use of effective workplace strategies to increase ... Works project administered by the Families and Work Institute (FWI) and the Society for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John Knox Village , ... of care for living and healing, celebrated its grand opening, today. The Woodlands at ... Home provided by Empowered Staff. , “This is an incredibly fulfilling time for John ...
Breaking Medicine News(10 mins):